Gavin Bennet
Company: Bicycle Therapeutics
Job title: Head of Pre-Clinical Development
Seminars:
Chair’s Closing Remarks 5:30 pm
day: Day Two
Bicycle Conjugates to Target Solid Tumors 8:40 am
Bicycles, constrained bicyclic peptides, offer antibody-like affinity and selectivity in a small molecule format Bicycle Toxin Conjugates are now in clinical development, offering rapid tumor penetration with limited plasma exposure Discover how Bicycles can be used to stimulate Immuno-oncology targets such as CD137, which can be targeted to tumor cells using Bicycle tumor-targeted immune cell…Read more
day: Day One
Chair’s Opening Remarks 8:30 am
day: Day One